Breaking point: Systemic mastocytosis manifesting as severe osteoporosis
Areti Kalfoutzou1, Kalliroi Spanou2, Adam Mylonakis3, Vassiliki Lagopoulou2, Maria Dimitrakoudi4, Alexandra Korovila5, Christos Piperis6, Eleni Tsiouri7 and Eleni Mostratou7
1 Department of Medical Oncology, 251 Air Force General Hospital, Athens 115 25, Greece
2 Department of Pathology, 251 Air Force General Hospital, Athens 115 25, Greece
3 First Department of Surgery, “Laiko” General Hospital, National and Kapodistrian University of Athens 115 27, Greece
4 Department of Hematology, “Laiko” General Hospital, National and Kapodistrian University of Athens 115 27, Greece
5 Department of Radiation Oncology, Alexandra Regional General Hospital, Athens 115 28, Greece
6 Department of Cardiology, “Georgios Gennimatas” General Hospital, Athens 115 27, Greece
7 Second Department of Internal Medicine, 251 Air Force General Hospital, Athens 115 25, Greece
Correspondence to:
Areti Kalfoutzou, email: [email protected]
Keywords: mastocytosis; mast cells; osteoporosis; anaphylaxis
Received: November 02, 2024 Accepted: January 27, 2025 Published: February 04, 2025
ABSTRACT
Systemic mastocytosis (SM) encompasses a wide spectrum of myeloproliferative disorders defined by the aggregation of abnormal mast cells in various tissues, including the bone marrow, gastrointestinal tract, liver and lymph nodes. The release of tryptase, interleukins and cytokines by the accumulated mast cells causes a multi-system response that can range from mild flushing and pruritus to severe anaphylactic reactions, gastrointestinal disturbances, and cardiovascular symptoms, including hypotension and syncope. Furthermore, severe osteoporosis manifesting as bone-lytic lesions or pathologic fractures due to mast cell mediator-triggered bone resorption, is a rather common manifestation of SM, occurring in more than two-thirds of patients. The vast majority of SM cases harbor the D816V KIT mutation, which is an independent prognostic factor, and serves as a therapeutic target. This is a rare case of a young male who presented with new-onset back pain due to osteoporotic fractures and was diagnosed with SM without the D816V KIT mutation. Our case aims to emphasize one of the most underrecognised causes of osteoporosis in adults, and to shed light on a frequently misdiagnosed yet potentially severe hematologic disorder.
PII: 614